Cereno's expanded access program for investigational therapy CS1 covers 10 PAH patients, following a Phase 2a clinical trial.

Topline data from the chronic cohort is expected in Q2 2025Institutional Review Board (IRB) protocol amendment changes ...

In June 2023, the Maharashtra government announced plans to convert popular bifocal courses in Mumbai into ...

Data support favorable safety and tolerability profile with no serious adverse events (SAEs) or study-related drug discontinuationsEnrollment to ...

Centessa Pharmaceuticals, founded from the merger of 10 biotech companies, is based on an asset-centric model, primarily ...

Psilocybin is under clinical development by Silo Pharma and currently in Phase II for Parkinson’s Disease. According to GlobalData, Phase II drugs for Parkinson’s Disease have a 41% phase transition ...

News stories about clinical trials testing potential treatments were among the top 10 most-read articles on ALS News Today in ...

EsoCap AG, the Swiss biotech company dedicated to improving the lives of patients with serious diseases of the upper gastrointestinal tract, announced today that the complete results of the ACESO ...

INR:2584. ind vs aus t20 world cup 2024 full match Merck releases Phase 2a study data: supports islatravir for pre-exposure prophylaxis F ...

INR:6252. horse racing program example Phase 3 clinical trial of dapagliflozin initiated; BIO-11006 therapy reached Phase 2a clinical endpoint Hengru ...

INR:4341. pro kabaddi today match prediction dream 11 This 12,000-word white paper concerns the new and old waves of every biopharmace ...

INR:0499. casino in melbourne Phase 3 clinical trial of dapagliflozin initiated; BIO-11006 therapy reached Phase 2a clinical endpoint Over 1 billion products!